Related Experiment Video
Updated: Jul 11, 2026
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions
Brenda Banwell1, Angelo Ghezzi, Amit Bar-Or
1Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, Canada. Brenda.banwell@sickkids.ca
Abstract:
The onset of multiple sclerosis (MS) in childhood poses diagnostic and therapeutic challenges, particularly if the symptoms of the first demyelinating event resemble acute disseminated encephalomyelitis (ADEM). MRI is an invaluable diagnostic tool but it lacks the specificity to distinguish ADEM from the first attack of MS. Advanced MRI techniques might have the required specificity to reveal whether the loss of integrity in non-lesional tissue occurs as a fundamental feature of MS. Although the onset of MS in childhood typically predicts a favourable short-term prognosis, some children are severely disabled, either physically or cognitively, and more than 50% are predicted to enter the secondary-progressive phase of the disease by the age of 30 years. Immunomodulatory therapies for MS and their safe application in children can improve long-term prognosis. Genetic and environmental factors, such as viral infection, might be uniquely amenable to study in paediatric patients with MS. Understanding the immunological consequences of these putative exposures will shed light on the early pathological changes in MS.
Insights
Childhood-onset multiple sclerosis (MS) presents diagnostic challenges, as initial symptoms can mimic acute disseminated encephalomyelitis (ADEM). Advanced MRI may help differentiate these conditions and guide early immunomodulatory treatment for better long-term outcomes.
Area of Science:
- Neurology
- Pediatrics
- Radiology
Background:
- Childhood-onset multiple sclerosis (MS) presents diagnostic and therapeutic challenges.
- Differentiating the first demyelinating event from acute disseminated encephalomyelitis (ADEM) is difficult using standard MRI.
- Early MS onset in children can lead to severe disability and progression to secondary-progressive MS.
Purpose of the Study:
- To explore advanced MRI techniques for distinguishing pediatric MS from ADEM.
- To investigate the role of non-lesional tissue integrity in early MS pathology.
- To understand the impact of immunomodulatory therapies on long-term prognosis in pediatric MS.
Main Methods:
- Utilizing advanced Magnetic Resonance Imaging (MRI) techniques.
- Analyzing tissue integrity in non-lesional areas.
- Reviewing outcomes of immunomodulatory therapies in pediatric MS patients.
Main Results:
- Standard MRI lacks specificity in differentiating ADEM from early MS.
- Advanced MRI may offer enhanced specificity for diagnosing pediatric MS.
- Early intervention with immunomodulatory therapies can improve long-term prognosis.
Conclusions:
- Advanced MRI holds promise for improving the diagnosis of childhood MS.
- Understanding early pathological changes, potentially influenced by genetic and environmental factors, is crucial.
- Timely and safe application of immunomodulatory therapies is vital for pediatric MS patients.
